Cover Image
Market Research Report
Product code
1018675

North America Alopecia (Hair Loss) Treatment Market Forecast 2021-2028

Published: | Inkwood Research | 122 Pages | Delivery time: 2-3 business days

Price

Back to Top
North America Alopecia (Hair Loss) Treatment Market Forecast 2021-2028
Published: July 19, 2021
Inkwood Research
Content info: 122 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The North America alopecia (hair loss) treatment market is evaluated to record a CAGR of 4.40% over the forecasting period of 2021 to 2028. Key factors such as the growing emphasis on aesthetics, the well-established presence of pharmaceutical firms working towards the effective treatment of alopecia, the rising disposable income, and the increased consumption of alcohol predominantly fuel the regional market's growth.

MARKET INSIGHTS

The North America alopecia (hair loss) treatment market growth assessment entails the evaluation of Canada and the United States. Canada houses multiple non-profit organizations as well as hair specialist salons endeavoring towards treating alopecia. In this regard, Canada's charitable organization named, Canadian Alopecia Areata Foundation (CANAAF) is mainly dedicated to the condition's treatment. It predominantly extends support to individuals diagnosed with alopecia areata in Canada. The organization also promotes education and awareness regarding such autoimmune diseases and raises substantial funds for research, as well.

Conversely, Canada has a non-profit organization committed to educating, advocating, and supporting citizens living with alopecia conditions, skin diseases, and traumas. The country also witnesses a considerable rise in smoking and alcohol consumption, resulting in increased hair loss complications among Canadian adults. As a result, these factors play an essential role in facilitating the North America alopecia (hair loss) treatment market growth over the estimated years.

COMPETITIVE INSIGHTS

Some of the major companies operating in the market are: Johnson & Johnson Inc, Concert Pharmaceuticals, Merk & Co Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 23927

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. RISE IN AUTOIMMUNE DISEASES
    • 3.1.2. HIGH CONSUMPTION OF ALCOHOL AND TOBACCO
    • 3.1.3. UNHEALTHY DIETARY HABITS
    • 3.1.4. STRESS AND CHANGING LIFESTYLES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. RISK OF INFECTIONS OR SIDE EFFECTS
    • 3.2.2. HIGH COSTS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON ALOPECIA (HAIR LOSS) TREATMENT MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY GENDER

  • 5.1. FEMALE
  • 5.2. MALE

6. MARKET BY INDICATIONS

  • 6.1. ANDROGENIC ALOPECIA
  • 6.2. ALOPECIA AREATA
  • 6.3. ALOPECIA TOTALIS
  • 6.4. OTHER INDICATIONS

7. MARKET BY DISTRIBUTION CHANNELS

  • 7.1. DRUG STORES & RETAIL PHARMACIES
  • 7.2. HOSPITAL PHARMACIES
  • 7.3. ONLINE PHARMACIES

8. MARKET BY TREATMENT

  • 8.1. TOPICAL
    • 8.1.1. MINOXIDIL
    • 8.1.2. SHAMPOOS
  • 8.2. ORAL
    • 8.2.1. FINASTERIDE
    • 8.2.2. OTHER ORAL HAIR LOSS TREATMENT
  • 8.3. OTHER TREATMENT TYPES

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED STATES
      • 9.1.5.2. CANADA

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGERS & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS & AGREEMENTS
    • 10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 10.2. COMPANY PROFILES
    • 10.2.1. ACLARIS THERAPEUTICS
    • 10.2.2. CELLMID
    • 10.2.3. CIPLA LTD
    • 10.2.4. CONCERT PHARMACEUTICALS
    • 10.2.5. DAIICHI SANKYO
    • 10.2.6. DR. REDDY'S LABORATORIES
    • 10.2.7. JOHNSON AND JOHNSON
    • 10.2.8. LEXINGTON INTERNATIONAL
    • 10.2.9. MERK & CO INC
    • 10.2.10. SHISEIDO COMPANY LIMITED
    • 10.2.11. SUN PHARMACEUTICAL INDUSTRIES LTD
    • 10.2.12. TAISHO PHARMACEUTICALS CO LTD THE HIMALAYA DRUG COMPANY
    • 10.2.13. TEVA PHARMACEUTICALS INDUSTRIES LTD
    • 10.2.14. THE HIMALAYA DRUG COMPANY
    • 10.2.15. TRANSITION HAIR PVT LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - ALOPECIA (HAIR LOSS) TREATMENT MARKET
  • TABLE 2: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY INDICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA L ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DISTRIBUTION CHANNELS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: LEADING PLAYERS OPERATING IN NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET
  • TABLE 17: LIST OF MERGERS & ACQUISITIONS
  • TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: PREVALENCE OF DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES 2019
  • FIGURE 2: KEY MARKET TRENDS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020
  • FIGURE 7: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY INDICATIONS, IN 2020
  • FIGURE 10: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)
  • FIGURE 12: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNELS, IN 2020
  • FIGURE 15: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)
  • FIGURE 16: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)
  • FIGURE 17: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2020
  • FIGURE 19: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY TOPICAL HAIR LOSS TREATMENT, IN 2020
  • FIGURE 21: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)
  • FIGURE 22: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
  • FIGURE 24: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, GROWTH POTENTIAL, BY ORAL HAIR LOSS TREATMENT, IN 2020
  • FIGURE 25: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)
  • FIGURE 26: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 27: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2028 (IN $ MILLION)
  • FIGURE 28: NORTH AMERICA ALOPECIA (HAIR LOSS) TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 29: UNITED STATES ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: CANADA ALOPECIA (HAIR LOSS) TREATMENT MARKET, 2021-2028 (IN $ MILLION)